item management s discussion and analysis of financial condition and results of operation overview sight resource corporation the company provides a complete range of eye care products and services through integrated networks of opticians  optometrists and ophthalmologists 
the company s services are provided primarily to persons with common vision disorders  as well as to persons with sight threatening conditions 
the company s operations currently consist of eye care centers  a centralized optical laboratory and distribution center  two management service organizations msos and ten laser vision correction lvc centers which the company has established in association with leading hospitals  ambulatory surgery centers and ophthalmologists 
in october  the fda first approved the use of one manufacturer s excimer laser for the treatment in the united states of nearsightedness using lvc 
in march  the fda approved a second manufacturer s excimer laser for the same treatment 
the company had commenced consolidation of its united kingdom operations during the third quarter of fiscal and  following the fda s initial approval  had fully discontinued these operations by the fourth quarter of fiscal the company s objective is to become the leading integrated provider of eye care products and services in select  regional markets 
to develop significant regional integrated networks  the company s business strategy focuses on i acquiring and integrating the assets of regional multi site eye care centers and the practices of eye care professionals optometrists and ophthalmologists  ii employing or entering into management services contracts with these professionals  iii continuing to market comprehensive and competitively priced eye care programs to leading hmos  insurance companies and other third party payors in the company s regional markets  iv expanding strategic affiliations  for pathology co management opportunities  with select hospitals  ambulatory surgery centers and eye care professionals and v continuing to market and provide access to lvc services through the company s eye care centers 
the company believes that its integrated approach to eye care provides significant advantages  benefits and opportunities to patients  providers and payors 
patients benefit from the convenience of eye care products and services delivered at a single location 
eye care professionals benefit from the supplemental management and administrative services and resources provided by the company  permitting them to continue to dedicate their time and effort to their patients and professional practices 
payors benefit from the company s ability to conveniently provide a complete range of eye care products and services with the highest quality at the lowest cost 
as compared with revenue 
the company generated net revenue of approximately million during the year ended december   from the operation of its eye care centers and ten laser vision correction centers in the united states as compared to net revenue of approximately million from its eye care centers and its network of laser vision correction centers in the united kingdom uk for the same period in of the million  or  increase in net revenue for the year ended december  as compared to the year ended december   million relates to the additional forty two eye care centers acquired effective july  the remaining increase of million relates to a full year of revenue from the vision world acquisition as well as the company s first full years of lvc services in the us cost of revenue 
cost of revenue decreased as a percent of net revenue from approximately million for the year ended december   to approximately million for the year ended december  the decrease as a percentage of net revenue is attributable to an increase in lvc procedures as well as manufacturing efficiencies realized at the company s central lab 
cost of revenue for the years ended december  and principally consisted of i the cost of manufacturing  purchasing and distributing optical products to its customers and ii the cost of delivering lvc  including depreciation and maintenance on excimer lasers 
selling  general and administration expenses 
selling  general and administration expenses were approximately million and million for the years ended december  and  respectively 
the increase primarily relates to payroll and facility costs incurred in operating additional eye care centers in as compared to selling  general and administrative expenses  as a percentage of net revenue  declined from for the year ended december   to for the year ended december  this decrease is a result of operating efficiencies which the company began to realize from the acquisition and expansion of multi site eye care centers and an increase in lvc revenue 
impairment of ophthalmic equipment 
during the fourth quarter of the company recognized a million write down due to impairment of ophthalmic equipment 
operating losses sustained during from the operation of this equipment coupled with anticipated future operating losses over the remaining depreciable life of the equipment resulted in the company s decision to recognize the impairment 
other income and expenses 
interest income totaled approximately  and  for the years ended december  and  respectively 
this increase resulted from the investment of a higher average cash and cash equivalents balance during as compared to interest expense remained comparable at approximately  and  for the years ended december  and  respectively 
the company also recorded a  foreign currency translation gain on the liquidation of the uk business at the close of net loss 
the company realized a net loss of approximately million per share and million per share for the years ended december  and  respectively 
the increase in net loss is primarily attributable to the million impairment of ophthalmic equipment recognized in the fourth quarter of offset by an increase in volume of laser vision correction services as well as six months of operations of the forty two eye care centers acquired effective july  as compared with revenue 
revenue for the year ended december  amounted to approximately million compared to  for the same period in the significant increase resulted from revenue generated by the company s newly acquired optical chains 
cost of revenue 
cost of revenue for the year ended december  was approximately million as compared to approximately  for the same period in the increase resulted from the inclusion of costs associated with the sale of optical products by the company s newly acquired optical chains 
the company operates a centralized laboratory and distribution center which provides comprehensive services to all of its eye care centers 
included in cost of revenue in is the cost of manufacturing and delivering the optical products to its customers in the us  as well as the costs to deliver laser vision correction in the uk including depreciation and maintenance on lasers of over million 
included in cost of revenue in is depreciation and maintenance on its excimer lasers in the uk  the company s most significant costs under the company s joint venture agreement with british united provident association bupa 
selling  general and administrative expenses 
selling  general and administrative expenses were approximately million and million for the years ended december  and  respectively 
the majority of the increase relates to the costs of operating eye care centers during in addition  the company continued to incur costs to develop and execute the company s us business plan 
included in selling  general and administrative expenses in  were costs of occupancy and personnel at the eye care centers  advertising and marketing programs in the us and uk  payroll and office expenses in the us and uk  severance and other costs associated with closing the uk office  legal and accounting  and other general and administrative expenses 
in  selling  general and administrative expenses primarily consisted of costs incurred operating the network of bupa sight resource laser vision correction centers in the uk 
other income and expense 
interest income increased from approximately  for the year ended december  to approximately  for the comparable period in this increase is a result of interest earned on the invested proceeds received from the company s second public offering in september  and the exercise of the ipo warrants in october interest expense for the year ended december  of approximately  represents interest on the revolving credit agreement and the long term debt which was assumed as part of the acquisition of cambridge eye 
the company also recorded a  foreign currency translation gain on the liquidation of the uk business at the close of in  the company had incurred thousand of financing costs in conjunction with the issuance of the bridge notes and class a warrants 
net loss 
for the year ended december   the company recorded a net loss of approximately million or per share as compared to a net loss of approximately million or per share for the same period in liquidity and capital resources at december   the company had approximately million in cash and cash equivalents and working capital of approximately million in comparison to approximately million in cash and cash equivalents and working capital of approximately million as of december  in  the company issued  shares of common stock to the public for net proceeds of approximately million 
the company anticipates using the net proceeds for working capital and other general corporate purposes  including acquisitions 
as of december   the company had securities outstanding which provide it with potential sources of financing as outlined below securities potential proceeds warrants   class a warrants   unit purchase options   ipo representative warrants   representative warrants   there can be no assurance that the company will obtain any such proceeds from the exercise of the above securities 
on february   the company entered into a credit agreement the agreement with a bank pursuant to which the company can borrow million on a term loan basis and million on a revolving credit basis  subject to certain performance criteria 
these loans are secured by all assets of the company and its wholly owned subsidiaries 
amounts borrowed under the agreement will be used to refinance existing debt  finance future acquisitions  provide ongoing working capital and for other general corporate purposes 
as part of the agreement  the company issued to the bank warrants to purchase  shares of the common stock at a purchase price of per share 
the warrants expire december  acquiring multi site eye care centers is a key component of the company s business strategy 
by acquiring multi site eye care centers  the company gains critical mass of locations ensuring that potential patients and third party payors will have convenient access to a wider variety of eye care services 
it also allows the company to deliver these services at considerable savings by using existing corporate and operational infrastructure  which includes store operations  mis  manufacturing  purchasing  distribution and training 
the company is currently evaluating potential acquisition candidates 
without additional funding  the company s rate of acquisition and size of acquisition could be limited 
the company anticipates that its working capital and sources of capital  such as the new credit facility  will be adequate to fund the company s currently proposed activities for at least the next twelve months 
the company anticipates using financing vehicles such as bank debt  leasing  and other sources of funding  such as additional equity offerings  to fund its operations 
there can be no assurance that the company will be successful in obtaining funds from any such sources 
if additional funds are raised by issuing equity securities  further dilution to the company s stockholders may result 
if additional funds are not available  the company may be required to delay execution of its business plan 

